The 11 currently reportable or Tier 1/actionable variants for NSCLC (ALK, EGFR, BRAF, KRAS, NTRK1, NTRK2, NTRK3, ROS, RET, MET and ERBB2) were verified and commercial control material was utilised to supplement the verification. Here, ERBB2 is linked to non-small cell lung carcinoma.